Holen Sie sich die Stockscreener-App
42.11
0.05%
0.02
Handel nachbörslich:
42.21
0.10
+0.24%
Schlusskurs vom Vortag:
$42.09
Offen:
$42.25
24-Stunden-Volumen:
37,670
Relative Volume:
0.85
Marktkapitalisierung:
$229.97M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.34%
1M Leistung:
+3.67%
6M Leistung:
-5.79%
1J Leistung:
+1.37%
1-Tages-Spanne:
$42.01
$42.55
1-Wochen-Bereich:
$41.81
$42.88
52-Wochen-Spanne:
$35.22
$48.76
Spdr Pharmaceuticals Etf Stock (XPH) Company Profile
Firmenname
Spdr Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XPH
Spdr Pharmaceuticals Etf
|
42.11 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
309.44 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
628.77 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
631.73 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
241.71 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
564.17 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Pharmaceuticals Etf Aktie (XPH) Neueste Nachrichten
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - The Globe and Mail
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' - Benzinga
XPH: Healthcare Dashboard For July (NYSEARCA:XPH) - Seeking Alpha
Short bets against S&P 500 healthcare stocks climb in June; MRNA tops list again - MSN
(XPH) Technical Data - news.stocktradersdaily.com
SA Quant's top healthcare picks amid Q2 earnings season - MSN
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies - Benzinga
The Tariff Tipping Point: Navigating Copper and Pharma Markets in an Era of Trade Rigidity - AInvest
U.S. Tariffs on Copper and Pharmaceuticals: Navigating Sector Shifts and Portfolio Risks - AInvest
Trump's Tariff Tsunami: Navigating Copper Gains and Pharma Headwinds - AInvest
Trading (XPH) With Integrated Risk Controls - news.stocktradersdaily.com
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' - Yahoo Finance
Global pharma stocks down as Trump renews tariff threat - MSN
Wealthcare Advisory Partners LLC Takes $339,000 Position in SPDR SSgA Ultra Short Term Bond ETF (NYSEARCA:ULST) - Defense World
Short bets on S&P 500 Healthcare sector ease in May; MRNA stays most shorted stock - MSN
Kalkine Reports Surge in SPDR S&P 500 Pharma ETF Trading Activity - Kalkine Media
Friday's ETF with Unusual Volume: XPH - Nasdaq
Cetera Investment Advisers Sells 718 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Ameriprise Financial Inc. Decreases Stock Position in SPDR S&P Bank ETF (NYSEARCA:KBE) - Defense World
2,299 Shares in SPDR S&P Aerospace & Defense ETF (NYSEARCA:XAR) Purchased by D. E. Shaw & Co. Inc. - Defense World
Invesco S&P 500 Pure Growth ETF (NYSEARCA:RPG) Stake Boosted by Ameriprise Financial Inc. - Defense World
D. E. Shaw & Co. Inc. Has $363,000 Stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by D. E. Shaw & Co. Inc. - Defense World
D. E. Shaw & Co. Inc. Decreases Holdings in SPDR S&P 600 Small Cap Growth ETF (NYSEARCA:SLYG) - Defense World
Bank of America Corp DE Sells 22,425 Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Navigating Geopolitical Storms: How Sector ETFs Can Turn Volatility into Opportunity - AInvest
Trump Sparks New Chapter In Transatlantic Trade War: What The US Buys From Europe - Benzinga
Captrust Financial Advisors Increases Holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
SPDR S&P International Small Cap ETF (NYSEARCA:GWX) Shares Sold by Focus Partners Wealth - Defense World
1,953 Shares in SPDR S&P Semiconductor ETF (NYSEARCA:XSD) Acquired by Focus Partners Wealth - Defense World
US health authorities to set targets for lowering drug prices - Reuters
Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work - inkl
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing DistortionCVS Health (NYSE:CVS), Cigna Group (NYSE:CI) - Benzinga
Short bets against S&P 500 healthcare stocks climb in April; MRNA retains top shorted ranking - MSN
A Silent Crash Inside S&P’s Good Day - Forbes
Stock ETFs Surge on China Tariffs Pact; Bonds, Gold Falter - Yahoo Finance
ETFs on the Move Post U.S.-China Trade Deal - Nasdaq
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks - Benzinga
A Look at Pharma ETFs After Strong Q1 Earnings - Yahoo Finance
Raymond James Financial Inc. Invests $762,000 in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
SPDR S&P 400 Mid Cap Value ETF (NYSEARCA:MDYV) Shares Bought by Renaissance Technologies LLC - Defense World
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus - TradingView
Best health care ETFs: Top biotech, pharma and medical funds - Bankrate
Russell Investments Group Ltd. Purchases 420 Shares of SPDR MSCI USA Gender Diversity Index ETF (NYSEARCA:SHE) - Defense World
Bank of Montreal Can Reduces Stock Position in SPDR S&P Semiconductor ETF (NYSEARCA:XSD) - Defense World
Bank of Montreal Can Decreases Stock Position in SPDR NYSE Technology ETF (NYSEARCA:XNTK) - Defense World
SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Shares Bought by JPMorgan Chase & Co. - Defense World
Wells Fargo & Company MN Increases Stock Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) - Defense World
Roche (RHHBY): Significant U.S. Investment to Enhance Manufacturing and Innovation - Value The Markets
Finanzdaten der Spdr Pharmaceuticals Etf-Aktie (XPH)
Es liegen keine Finanzdaten für Spdr Pharmaceuticals Etf (XPH) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.13%
0.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):